Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 10,700 | 32,321 | 50,118 | 72,798 | 75,680 |
| Gross Profit | 10,700 | 32,321 | 50,118 | 72,798 | 75,680 |
| Operating Expenses | 100,656 | 128,856 | 125,072 | 128,029 | 111,799 |
| Operating Income | -89,956 | -96,535 | -74,954 | -55,231 | -36,119 |
| Interest Expense | 2,966 | 2,691 | 2,771 | 3,253 | 3,280 |
| Other Income | -497 | 2,342 | 6,492 | 4,054 | 3,203 |
| Pre-tax Income | -93,419 | -96,884 | -71,233 | -54,430 | -36,196 |
| Income Tax | -102 | N/A | N/A | -119 | 119 |
| Net Income Continuous | -93,317 | -96,884 | -71,233 | -54,311 | -36,315 |
| Net Income | $-93,317 | $-96,884 | $-71,233 | $-54,311 | $-36,315 |
| EPS Basic Total Ops | -3.99 | -3.92 | -4.13 | -5.67 | -3.99 |
| EPS Basic Continuous Ops | -4.49 | -4.96 | -4.99 | -5.68 | -3.97 |
| EPS Diluted Total Ops | -3.99 | -3.92 | -4.13 | -5.67 | -3.99 |
| EPS Diluted Continuous Ops | -4.49 | -4.96 | -4.99 | -5.68 | -3.97 |
| EBITDA(a) | $-81,656 | $-86,465 | $-64,532 | $-44,030 | $-24,463 |